EP1556024A4 - Zusammensetzungen von milnacipran mitpulsativer freisetzung - Google Patents

Zusammensetzungen von milnacipran mitpulsativer freisetzung

Info

Publication number
EP1556024A4
EP1556024A4 EP03809957A EP03809957A EP1556024A4 EP 1556024 A4 EP1556024 A4 EP 1556024A4 EP 03809957 A EP03809957 A EP 03809957A EP 03809957 A EP03809957 A EP 03809957A EP 1556024 A4 EP1556024 A4 EP 1556024A4
Authority
EP
European Patent Office
Prior art keywords
milnacipran
release compositions
pulsatile release
pulsatile
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP03809957A
Other languages
English (en)
French (fr)
Other versions
EP1556024A1 (de
Inventor
Jane Hirsh
Roman V Rariy
Michael Heffernan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Collegium Pharmaceutical Inc
Original Assignee
Collegium Pharmaceutical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Collegium Pharmaceutical Inc filed Critical Collegium Pharmaceutical Inc
Publication of EP1556024A1 publication Critical patent/EP1556024A1/de
Publication of EP1556024A4 publication Critical patent/EP1556024A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP03809957A 2002-10-25 2003-10-22 Zusammensetzungen von milnacipran mitpulsativer freisetzung Withdrawn EP1556024A4 (de)

Applications Claiming Priority (19)

Application Number Priority Date Filing Date Title
US42164002P 2002-10-25 2002-10-25
US421640P 2002-10-25
US43162602P 2002-12-05 2002-12-05
US43162702P 2002-12-05 2002-12-05
US431627P 2002-12-05
US431626P 2002-12-05
US43190602P 2002-12-09 2002-12-09
US43186102P 2002-12-09 2002-12-09
US431906P 2002-12-09
US431861P 2002-12-09
US44361803P 2003-01-29 2003-01-29
US443618P 2003-01-29
US45906103P 2003-03-28 2003-03-28
US45899403P 2003-03-28 2003-03-28
US45899503P 2003-03-28 2003-03-28
US458994P 2003-03-28
US458995P 2003-03-28
US459061P 2003-03-28
PCT/US2003/033685 WO2004039361A1 (en) 2002-10-25 2003-10-22 Pulsatile release compositions of milnacipran

Publications (2)

Publication Number Publication Date
EP1556024A1 EP1556024A1 (de) 2005-07-27
EP1556024A4 true EP1556024A4 (de) 2007-01-17

Family

ID=36650219

Family Applications (1)

Application Number Title Priority Date Filing Date
EP03809957A Withdrawn EP1556024A4 (de) 2002-10-25 2003-10-22 Zusammensetzungen von milnacipran mitpulsativer freisetzung

Country Status (6)

Country Link
EP (1) EP1556024A4 (de)
JP (1) JP2006506461A (de)
AU (1) AU2003301762B2 (de)
CA (1) CA2503121A1 (de)
MX (1) MXPA05004422A (de)
WO (1) WO2004039361A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003284005B2 (en) * 2002-10-03 2009-12-17 Forest Laboratories Holdings Limited Dosage escalation and divided daily dose of anti-depressants to treat neurological disorders
US20040121010A1 (en) * 2002-10-25 2004-06-24 Collegium Pharmaceutical, Inc. Pulsatile release compositions of milnacipran
AR042806A1 (es) 2002-12-27 2005-07-06 Otsuka Pharma Co Ltd Combinacion de derivados de carboestirilo e inhibidores de la reabsorcion de serotonina para el tratamiento de trastornos del animo
EP1575590B1 (de) 2002-12-27 2007-10-24 Otsuka Pharmaceutical Co., Ltd. Carbostyril-derivate mit selektiven serotonin-aufnahme inhibitoren, zur behandlung von gemütskrankheiten
TWI338583B (en) * 2004-05-20 2011-03-11 Otsuka Pharma Co Ltd Solid pharmaceutical formulation
EP1894565B1 (de) * 2005-06-10 2013-10-30 Pierre Fabre Médicament S.A. Stabilisierte milnacipran-formulierung
WO2007064845A1 (en) * 2005-11-29 2007-06-07 Pr Pharmaceuticals, Inc. Sustained release butorphanol drug delivery compositions for analgesia
US9265732B2 (en) 2006-03-06 2016-02-23 Pozen Inc. Dosage forms for administering combinations of drugs
CA2644435C (en) * 2006-03-06 2015-04-07 Pozen Inc. Dosage forms for administering combinations of drugs
AR071706A1 (es) * 2008-05-15 2010-07-07 Otsuka Pharma Co Ltd Una formulacion farmaceutica de cilostazol solida de liberacion sostenida y metodo de preparacion.
WO2011107921A2 (en) 2010-03-04 2011-09-09 Ranbaxy Laboratories Limited Modified release composition of milnacipran
WO2011107922A2 (en) 2010-03-04 2011-09-09 Ranbaxy Laboratories Limited Extended release composition of milnacipran
MX2013004123A (es) 2010-10-12 2013-12-16 Univ Johns Hopkins Composiciones antitusigenas que comprenden memantina.
US11464756B1 (en) 2017-05-19 2022-10-11 Jerry Darm Mecuna pruriens, L-DOPA and 5-HTP based dietary supplements, pharmaceutical formulations and uses thereof

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0759299A1 (de) * 1995-08-16 1997-02-26 Eli Lilly And Company Potenzierung von Serotonin-Wirkstoffresponz
WO1998008495A1 (fr) * 1996-08-28 1998-03-05 Pierre Fabre Medicament Forme galenique a liberation prolongee de milnacipran
WO1999059593A1 (en) * 1998-05-21 1999-11-25 Eli Lilly And Company Combination therapy for treatment of depression
WO2000040224A1 (en) * 1999-01-07 2000-07-13 Elan Corporation, Plc Multiparticulate oral dosage forms
JP2003277252A (ja) * 2002-03-20 2003-10-02 Asahi Kasei Corp 粒状被覆製剤の製造方法
WO2004037190A2 (en) * 2002-10-25 2004-05-06 Collegium Pharmaceutical, Inc. Modified release compositions of milnacipran
WO2004067039A1 (en) * 2003-01-28 2004-08-12 Collegium Pharmaceutical, Inc. Multiparticulate compositions of milnacipran for oral administration

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5609884A (en) * 1992-08-31 1997-03-11 G. D. Searle & Co. Controlled release naproxen sodium plus naproxen combination tablet
US6103263A (en) * 1994-11-17 2000-08-15 Andrx Pharmaceuticals, Inc. Delayed pulse release hydrogel matrix tablet
SE9704870D0 (sv) * 1997-12-22 1997-12-22 Astra Ab New pharmaceutical formulation I
WO2000059481A1 (en) * 1999-04-06 2000-10-12 Pharmaquest Ltd. PHARMACEUTICAL DOSAGE FORM FOR PULSATILE DELIVERY OF d-threo-METHYLPHENIDATE AND A SECOND CNS STIMULANT
EP1064937A1 (de) * 1999-06-28 2001-01-03 Sanofi-Synthelabo Pharmazeutische Zusammensetzungen mit kontrollierten Freigabe enthaltend ein Hypnotikum mit kurzer Wirkung oder deren Salze
AU6715600A (en) * 1999-08-26 2001-03-19 Elan Corporation, Plc Pharmaceutical formulations
US20020028240A1 (en) * 2000-04-17 2002-03-07 Toyohiro Sawada Timed-release compression-coated solid composition for oral administration
US20020132001A1 (en) * 2000-05-11 2002-09-19 Garthwaite Susan M. Aldosterone antagonist composition for release during aldosterone acrophase

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0759299A1 (de) * 1995-08-16 1997-02-26 Eli Lilly And Company Potenzierung von Serotonin-Wirkstoffresponz
WO1998008495A1 (fr) * 1996-08-28 1998-03-05 Pierre Fabre Medicament Forme galenique a liberation prolongee de milnacipran
WO1999059593A1 (en) * 1998-05-21 1999-11-25 Eli Lilly And Company Combination therapy for treatment of depression
WO2000040224A1 (en) * 1999-01-07 2000-07-13 Elan Corporation, Plc Multiparticulate oral dosage forms
JP2003277252A (ja) * 2002-03-20 2003-10-02 Asahi Kasei Corp 粒状被覆製剤の製造方法
WO2004037190A2 (en) * 2002-10-25 2004-05-06 Collegium Pharmaceutical, Inc. Modified release compositions of milnacipran
WO2004067039A1 (en) * 2003-01-28 2004-08-12 Collegium Pharmaceutical, Inc. Multiparticulate compositions of milnacipran for oral administration

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2004039361A1 *

Also Published As

Publication number Publication date
AU2003301762A1 (en) 2004-05-25
EP1556024A1 (de) 2005-07-27
JP2006506461A (ja) 2006-02-23
AU2003301762B2 (en) 2006-02-09
WO2004039361A1 (en) 2004-05-13
MXPA05004422A (es) 2007-11-22
CA2503121A1 (en) 2004-05-13

Similar Documents

Publication Publication Date Title
EP1578403A4 (de) Zusammensetzungen von milnacipran mit modifizierter freisetzung
EP1549296A4 (de) Metformin-formulierungen mit verzögerter freisetzung
TWI347198B (en) Fenofibrate compositions
PL1610784T3 (pl) Postacie 5-azacytydyny
ZA200508997B (en) Preparation of an osteoinductive agent
IL176584A0 (en) Photoresist compositions and processes of use
ZA200605348B (en) Solid forms of anti-EGFR-antibodies
GB0212062D0 (en) Jetable compositions
EP1477070A4 (de) Fett-zusammensetzung
IL152127A0 (en) Probiotic compositions for the treatment of inflammatory bowel disease
EP1603543A4 (de) Therapeutische zusammensetzungen
PL1615622T3 (pl) Preparaty doksycyklin do jednorazowego dziennego podawania
HK1089697A1 (en) Modafinil modified release pharmaceutical compositions
EP1556023A4 (de) Nahrungsergänzungs- oder therapeutische zusammensetzungen
EP1556024A4 (de) Zusammensetzungen von milnacipran mitpulsativer freisetzung
EP1608385A4 (de) Therapeutische zusammensetzungen
GB0208609D0 (en) Compositions
IL166591A0 (en) Preparation of aztreonam
EP1638394A4 (de) Hochkonzentrierte bromzusammensetzungen und verfahren zu ihrer herstellung
GB0229258D0 (en) Medicinal compositions
AU2003302372A8 (en) Formulations of finasteride
GB0221894D0 (en) Compositions
AU2003269904A8 (en) Antigen-polymer compositions
PL372655A1 (en) Compositions of pentafluoropropane
GB0222945D0 (en) Therapeutic compositions

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20050430

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20061215

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 9/48 20060101ALI20061211BHEP

Ipc: A61K 47/48 20060101AFI20061211BHEP

17Q First examination report despatched

Effective date: 20070823

RIN1 Information on inventor provided before grant (corrected)

Inventor name: SRINIVAS, G RAO, DR.

Inventor name: HEFFERNAN, MICHAEL

Inventor name: RARIY, ROMAN, V.

Inventor name: HIRSH, JANE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20110503